Literature DB >> 8221570

Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation.

J L Chin1, D Banerjee, S A Kadhim, T E Kontozoglou, P J Chauvin, M G Cherian.   

Abstract

BACKGROUND: Metallothioneins (MT) are endogenous metalloproteins involved in the homeostasis of essential metals and detoxification of toxic metals. Some recent experimental studies suggested tumor resistance to cisdiamminedichloroplatin may be associated with overexpression of MT in the tumor.
METHODS: The presence of MT in 33 primary testicular germ cell tumor specimens was assessed immunohistochemically using a rabbit polyclonal rat liver MT antibody that cross-reacted with human MT. The data were correlated with the patients' clinical course.
RESULTS: Seminomas stained weakly or not at all for MT, regardless of the clinical stage. Most nonseminomas stained heavily for MT. The more advanced staged nonseminomas tended to stain more heavily for MT.
CONCLUSIONS: In view of the considerable experimental evidence as well as some inferential clinical data involving MT in cis-diamminedichloroplatin resistance, there appears to be a role for MT in cis-diamminedichloroplatin resistance in germ cell tumors. Further studies to elucidate the role of MT in germ cell tumor chemoresistance are warranted.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221570     DOI: 10.1002/1097-0142(19931115)72:10<3029::aid-cncr2820721027>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Mechanisms of resistance to alkylating agents.

Authors:  G Damia; M D'Incalci
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

2.  Down-regulation of metallothionein 1 and 2 after exposure to electromagnetic field in mouse testis.

Authors:  Abbas Ebrahimi-Kalan; Mehryar Habibi Roudkenar; Raheleh Halabian; Peiman Broki Milan; Armin Zarrintan; Amaneh Mohammadi Roushandeh
Journal:  Iran Biomed J       Date:  2011

3.  Metallothionein expression in hepatocellular carcinoma.

Authors:  Geng-Wen Huang; Lian-Yue Yang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

4.  Immunohistochemical study of metallothionein in pancreatic carcinomas.

Authors:  G Ohshio; T Imamura; N Okada; Z H Wang; K Yamaki; T Kyogoku; H Suwa; H Yamabe; M Imamura
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia.

Authors:  A Sauerbrey; F Zintl; M Volm
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

6.  Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus.

Authors:  Y Hishikawa; T Koji; D K Dhar; S Kinugasa; M Yamaguchi; N Nagasue
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

Review 7.  Molecular functions of metallothionein and its role in hematological malignancies.

Authors:  Shinichiro Takahashi
Journal:  J Hematol Oncol       Date:  2012-07-27       Impact factor: 17.388

8.  P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma.

Authors:  S D Shnyder; A J Hayes; J Pringle; C W Archer
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

9.  Induction of hepatic metallothionein I in tumour-bearing mice.

Authors:  D M Kloth; J L Chin; M G Cherian
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

10.  Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma.

Authors:  P Coyle; G Mathew; P A Game; J C Myers; J C Philcox; A M Rofe; G G Jamieson
Journal:  Br J Cancer       Date:  2002-08-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.